Not exact matches
At 10 years
after transplantation, the organs from donors with unacceptable / high risk provided each
recipient with more than 7 additional years of survival on average.
Steatosis — when the liver becomes infiltrated with fat — occurs frequently
after liver
transplantation, but little is known about its actual prevalence in transplant
recipients, which risk factors are involved, or what effects the condition has on patients» survival.
Even with immunosuppressive therapy, 10 to 15 percent of kidney
recipients experience rejection during the first year
after transplantation.
Transplant
recipients with low urinary CXCL9 protein six months
after transplantation were unlikely to experience rejection or loss of kidney function over the next 18 months.
The researchers then assessed the prevalence of a kind of immune cell called a myeloid cell, which were derived from the donated stem cells in the blood of the
recipient mice, at eight and 16 weeks
after transplantation.
Months to years
after transplantation, retinal cells derived from human embryonic stem cells appear healthy — and may have unexpectedly helped vision in some
recipients
After analyzing information on 88,209 donors (176,418 kidneys), the researchers found that although the discarded kidneys in these pairs frequently had traits that are typically considered unappealing, the partner kidneys that shared many, if not all of the same traits performed well after being used for transplantation despite being used in older recipients with more medical prob
After analyzing information on 88,209 donors (176,418 kidneys), the researchers found that although the discarded kidneys in these pairs frequently had traits that are typically considered unappealing, the partner kidneys that shared many, if not all of the same traits performed well
after being used for transplantation despite being used in older recipients with more medical prob
after being used for
transplantation despite being used in older
recipients with more medical problems.
We have also generated T - regs (CD4 + / 25high / 127low / --RRB- in vitro from donor AD - MSC and
recipient peripheral blood mononuclear cells and these T - regs are infused in thymus of renal allograft
recipients after kidney
transplantation.
Hematopoietic stem cells express the markers CD34 and CD133 and can repopulate a myeloablated
recipient after allogeneic or autologous
transplantation.
VPA (300 mg / kg / d) was injected i.p. into T cell
recipients from day 0
after transplantation (n = 20), with vehicle treatment as control (n = 20).
We then treated BMT
recipients with VPA or vehicle and recovered donor T cells from spleen and MLN of
recipients on the indicated days
after transplantation.